Also in the News…
From clinical trial results to glaucoma disparities, these are the news stories and studies that caught our attention this week…
Alun Evans | | News
Lesley A Butler from Melbourne, Australia, CC BY-SA 2.0 <https://creativecommons.org/licenses/by-sa/2.0>, via Wikimedia Commons
TENEO clinical trial results. Bausch + Lomb announces the publication of its TENEO Excimer Laser clinical trial results, supporting the use of TENEO for myopia and myopic astigmatism LASIK vision correction surgery. Link
New ASOA executive director. Abby Markway, ASCRS (American Society of Cataract and Refractive Surgery) Foundation director, will take on the additional role as executive director of ASOA (American Society of Ophthalmic Administrators). Link
New findings for Sjogren’s Syndrome. Researchers from the Australian National University, Australia, and Shanghai Jiaotong University, China, have discovered a rare mutated version of the TNIP1 protein, which can cause a chronic autoimmune disorder similar in nature to Sjogren’s Syndrome. The scientists were able to reverse the effects of the mutation in mice models, bringing hope for more targeted therapeutics in humans. Link
Subjective distortion. How do patients with visual disorders – such as metamorphosis – actually see the world? A team from Guy's and St Thomas' NHS Foundation Trust, London, devised the “Image Warping Test” – a computer-based approach that reverse-engineers a subject’s visual distortion to create “a digital map of subjective metamorphopsia” for clinicians. The team reports that the software could be used for non-invasive treatments, using real-time feedback to inversely map distortion into a head mounted video display worn by the surgeon. Link
Indicators of GA progression. A new TVST study by researchers from Genentech has examined how fundus autofluorescence (FAF) might contribute to the effectiveness of deep learning (DL) algorithms for detecting geographic atrophy (GA) progression. Determining which regions of the eye might be most beneficial for the algorithm to accurately gauge GA progression, the team discovered that the rim region (the border area around the lesion) revealed the most about the disease’s development. Link
Glaucoma demographics. Looking at a wide variety of variables (including race, gender, ethnicity, and language) and how they affect glaucoma progression and visual field (VF) loss, scientists from Mass Eye and Ear have reported that Black patients and non-English speakers experience more severe VF loss from glaucoma. The findings may help in the development of more effective glaucoma screening programs, while enhancing future community outreach efforts, the authors say. Link
The Ophthalmologist Presents:
Enjoying yourself? There's plenty more where that came from! Our weekly newsletter from The Ophthalmologist brings you the most popular stories as they unfold, chosen by our fantastic Editorial team!
